Please assess the completion status of the following clinical trial:

Trial Title: Standalone OMNI Surgical System for Open-angle Glaucoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria~* Patients aged 30-95 with primary or pigmentary / pseudoexfolliative / juvenile / normal pressure open angle glaucoma or combined mechanism glaucoma.~* An IOP of 10-40 mmHg on maximum tolerated medical therapy who are either progressing, above IOP target, or poorly adherent or tolerant to medical therapy.~* Phakic or pseudophakic eyes and previous laser trabeculoplasty will be included.~Exclusion Criteria:~* Other forms of glaucoma,~* prior incisional glaucoma surgery,~* prior corneal graft (PKP, DALK, DSAEK, DMEK),~* Shafer angle grading \<2 in 2 or more quadrants.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 95 Years
- Healthy Volunteers: None

Study Arms:
- Oen Angle Glaucoma (Type: None): • Patients aged 30-95 with primary or pigmentary / pseudoexfolliative / juvenile / normal pressure open angle glaucoma or combined mechanism glaucoma with IOP of 10-40 mmHg on maximum tolerated medical therapy who are either progressing, above IOP target, or poorly adherent or tolerant to medical therapy. Phakic or pseudophakic eyes and previous laser trabeculoplasty will be included.

Based on this trial design, predict the completion outcome and termination type (if applicable).